Next Article in Journal
Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation
Next Article in Special Issue
Benzoxaboroles—Novel Autotaxin Inhibitors
Previous Article in Journal
Water Extraction Kinetics of Bioactive Compounds of Fucus vesiculosus
Previous Article in Special Issue
Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents
Open AccessArticle

Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration

by Soyoung Hwang 1, Dong Min Shin 2,*,† and Jeong Hee Hong 1,*,†
1
Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University, 155 Getbeolro, Yeonsu-gu, Incheon 21999, Korea
2
Department of Oral Biology, BK21 PLUS Project, Yonsei University College of Dentistry, Seoul 03722, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editors: Jean Jacques Vanden Eynde, Annie Mayence and Tien L. Huang
Molecules 2019, 24(18), 3409; https://doi.org/10.3390/molecules24183409
Received: 7 August 2019 / Revised: 15 September 2019 / Accepted: 17 September 2019 / Published: 19 September 2019
Disulfiram has been used in the treatment of alcoholism and exhibits an anti-tumor effect. However, the intracellular mechanism of anti-tumor activity of Disulfiram remains unclear. In this study, we focused on the modulatory role of Disulfiram via oncogenic factor carbonic anhydrase CA12 and its associated transporter anion exchanger AE2 in lung cancer cell line A549. The surface expression of CA12 and AE2 were decreased by Disulfiram treatment with a time-dependent manner. Disulfiram treatment did not alter the expression of Na+-bicarbonate cotransporters, nor did it affect autophagy regulation. The chloride bicarbonate exchanger activity of A549 cells was reduced by Disulfiram treatment in a time-dependent manner without change in the resting pH level. The expression and activity of AE2 and the expression of CA12 were also reduced by Disulfiram treatment in the breast cancer cell line. An invasion assay and cell migration assay revealed that Disulfiram attenuated the invasion and migration of A549 cells. In conclusion, the attenuation of AE2 and its supportive enzyme CA12, and the inhibitory effect on cell migration by Disulfiram treatment in cancer cells provided the molecular evidence supporting the potential of Disulfiram as an anticancer agent. View Full-Text
Keywords: disulfiram (DSF); drug repurposing; antitumor agent; cancer cell migration disulfiram (DSF); drug repurposing; antitumor agent; cancer cell migration
Show Figures

Figure 1

MDPI and ACS Style

Hwang, S.; Shin, D.M.; Hong, J.H. Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration. Molecules 2019, 24, 3409.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop